|
|
|
Applied Dna Scns 
|
9.93 -1.08 (-0.1%) |
01-21 09:41 |
Open: |
10 |
Pre close: |
11.01 |
Target:
|
15.03
|
High: |
10.65 |
Low: |
9.8 |
Resistance:
|
12.87
15.03
|
Volume: |
378,336 |
Market Cap: |
74M |
Support:
|
7.98
4.95
|
|
|
|
Technical Analysis |
Moving Averages |
MA(5):
|
10.22
 |
MACD |
MACD(12,26):
|
1.17  |
MA(20): |
7.28  |
Signal(12,26,9): |
0.63  |
MA(100): |
7.32  |
Stochastic Oscillator |
%K(14,3):
|
76.89  |
MA(250): |
7.12  |
%D(3): |
68.89  |
Average Volume(K) |
3-Month: |
110364
|
52-Week |
High:
|
16.39 |
10-Days: |
506375 |
Low: |
2.52 |
RSI |
RSI(14):
|
68.02  |
Change(%): |
173.9 |
Financials, Statistics and Valuation |
EPS |
-3.330 |
Return on Equity (ttm) |
-536.1 |
Shares Out. (M) |
5.66 |
EPS Est. Current Year |
-0.440 |
Return on Assets (ttm) |
-105.1 |
Shares Float (M) |
4.95 |
EPS Est. Next Year |
-0.230 |
PEG Ratio |
0.00 |
% Held by Insiders |
13.83 |
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-81.2 |
% Held by Institutions |
12.07 |
Forward EPS |
-9.690 |
Gross Profit (p.s.) |
0.214 |
Shares Short (K) |
662 |
Book Value (p.s.) |
1.110 |
EBITDA (p.s.) |
-2.164 |
P/E |
-3.31 |
Sales Per Share |
0.341 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.92 |
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.14 |
P/S |
32.29 |
Operating Margin |
-648.98 |
Levered Free Cash Flow
(M) |
-7.17 |
P/CF |
-5.59 |
|
|
|
|
|